Literature DB >> 3357118

Active and passive immunization of mice against larval Dirofilaria immitis.

D Abraham1, R B Grieve, M Mika-Grieve, B P Seibert.   

Abstract

The objective of this study was to determine if Dirofilaria immitis larvae would survive in diffusion chambers implanted in dogs and mice and secondly to determine if mice could be immunized against infection with D. immitis. Dirofilaria immitis third-stage larvae (L3) survived and grew in diffusion chambers implanted in dogs and mice for at least 3 wk. BALB/c mice, which were repeatedly infected with live L3, showed resistance to challenge infections. Dead L3, with or without adjuvants elicited no protective immunity. A correlation was found between the degree of immune protection seen in mice and antibody levels to soluble larval antigen but not to antibody levels to surface antigens. A monoclonal antibody was prepared that reacted with the surface of D. immitis and Onchocerca lienalis L3, but not to the surfaces of other stages and species of various filarial worms. When this antibody was administered to mice prior to challenge no significant reduction in larval survival was observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357118

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  5 in total

Review 1.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds.

Authors:  Ramaswamy Kalyanasundaram; Padmavathi Balumuri
Journal:  Res Rep Trop Med       Date:  2011-03

3.  Calgranulin C has filariacidal and filariastatic activity.

Authors:  J D Gottsch; S W Eisinger; S H Liu; A L Scott
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  The host-parasite relationship in canine heartworm infection in a hyperendemic area of Italy.

Authors:  G Capelli; G Poglayen; F Bertotti; S Giupponi; M Martini
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.